Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)

head and neck squamous cell carcinoma, colorectal cancer, non small cell lung cancer, epidermal growth factor receptor inhibitor, prevention strategy, cutaneous toxicity, quality of life, patient satisfaction, dermatology life quality index (dlqi), epidermal repair score (scorepi), topical treatment, interventional